secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bio Green Med Solution, Inc. (BGMS)
CIK:        0001130166
Form:       8-K
Filed at:   2023-12-26T23:59:59+00:00
Accession:  0001104659-23-129018
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Cyclacel raises $1.29M through registered direct and private placements of stock and warrants
--------------------------------------------------------------------------------

- Gross proceeds ~$1.29M from sale of 388,200 shares/pre-funded warrants at $3.315/share to institutional investors.
- Issues unregistered warrants to purchase 388,200 shares at $3.19 each, exercisable for 7 years.
- Insiders (CEO and CFO) purchase 7,956 shares and warrants on same terms in concurrent private placement.
- Ladenburg Thalmann acts as placement agent; fees 8% of gross proceeds plus warrants.
- Closing expected December 26, 2023; proceeds for working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1130166/000110465923129018/0001104659-23-129018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1130166/000110465923129018/tm2333683d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-129018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer